Health TrialsbyHealthPanel

Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Study to Investigate the Effects and Safety of Codabakalner for the Treatment of FXS in Male Participants and Adult Participants With ADS

This is a Study to Investigate the Effects and Safety of Codabakalner for the Treatment of Fragile X Syndrome in Male Participants and Adult Participants with Autism Spectrum Disorders

Participants needed: 120
Trial details
Phase: Phase 2, Phase 3Age: 18-45Biological sex: MaleType: InterventionalSponsor: SpinogenixUpdated: Oct 9, 2026
Eligibility criteria

Phase 2b: Adult males aged 18 to 45 years, inclusive Phase 3: Males aged 13-45 y... [+4]

Any physical or psychological condition that prohibits study completion [+8]

Read more
Status: Available

Intermediate-size Patient Population Expanded Access Protocol

The purpose of this Expanded Access Program is to provide tazbentetol to ALS patients who are not eligible to enroll in an ALS clinical trial. This Expanded Access Program will assess safety and tolerability, and clinical efficacy of tazbentelol.

Trial details
Age: 18-85Biological sex: AllType: Expanded AccessSponsor: SpinogenixUpdated: Sep 25, 2026Locations: 16
Eligibility criteria

ALS diagnosis [+5]

Clinically significant and/or unstable medical condition (other than ALS) that w... [+5]

Read more
Status: Not yet recruiting

Efficacy and Safety of Tazbentetol in ALS Participants

The objectives of this study are to examine the effects of tazbentetol on clinical measures of ALS, patient reported outcomes (PROs), long-term safety and tolerability.

Participants needed: 430
Trial details
Phase: Phase 2, Phase 3Age: 18-80Biological sex: AllType: InterventionalSponsor: SpinogenixUpdated: Sep 10, 2026
Eligibility criteria

Age 18-80 [+4]

Underlying physical or psychological condition prohibiting study completion [+14]

Read more